ABETAP Trademark

Trademark Overview

On Tuesday, February 23, 2021, a trademark application was filed for ABETAP with the United States Patent and Trademark Office. The USPTO has given the ABETAP trademark a serial number of 90540931. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Wednesday, October 1, 2025. This trademark is owned by Amprion, Inc.. The ABETAP trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Medical diagnosis of neurodegenerative diseases
abetap

General Information

Serial Number90540931
Word MarkABETAP
Filing DateTuesday, February 23, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateWednesday, October 1, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 12, 2022

Trademark Statements

Pseudo MarkABE TAP
Goods and ServicesMedical diagnosis of neurodegenerative diseases

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, May 24, 2021
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAmprion, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94105
Party NameAmprion, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94105

Trademark Events

Event DateEvent Description
Friday, September 17, 2021ASSIGNED TO EXAMINER
Monday, September 20, 2021NON-FINAL ACTION E-MAILED
Friday, February 26, 2021NEW APPLICATION ENTERED
Monday, May 24, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, September 20, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, September 20, 2021NON-FINAL ACTION WRITTEN
Tuesday, April 12, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, February 7, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 8, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 7, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 9, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 23, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 12, 2022PUBLISHED FOR OPPOSITION
Tuesday, June 7, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sunday, December 3, 2023SOU TEAS EXTENSION RECEIVED
Sunday, December 3, 2023SOU EXTENSION 3 FILED
Tuesday, December 6, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, December 6, 2022SOU EXTENSION 1 FILED
Tuesday, December 6, 2022SOU EXTENSION 1 GRANTED
Thursday, December 8, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 26, 2023SOU TEAS EXTENSION RECEIVED
Friday, May 26, 2023SOU EXTENSION 2 FILED
Friday, May 26, 2023SOU EXTENSION 2 GRANTED
Tuesday, May 30, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, December 3, 2023SOU EXTENSION 3 GRANTED
Wednesday, December 6, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 7, 2024SOU EXTENSION 4 GRANTED
Thursday, June 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 1, 2025ABANDONMENT - NO USE STATEMENT FILED
Wednesday, October 1, 2025ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Friday, June 7, 2024SOU EXTENSION 4 FILED
Friday, June 7, 2024SOU TEAS EXTENSION RECEIVED

Related Keywords

abetap diseases neurodegenerative diagnosis medical